Soaring premiums and new transparency rules are pushing companies to seek cheaper, nontraditional health insurers and ...
BENGALURU: In view of the state government itself informing that valuation of SSLC examination answer scripts of the academic ...
If the governor signs a measure into law the retailer says the only choice is to close locations, promises to challenge in ...
Health insurers have grown bigger, more powerful and more deeply embedded in our healthcare system than ever before. But if ...
Don't blame a menopause fad. There is little incentive for pharmacy companies to ensure smooth, consistent access.
Rapidly growing pharmaceutical services platform expands life sciences consulting capabilities with key leadership additions NASHVILLE, Tenn., April 20, 2026 /PRNewswire/ -- Petauri, a purpose-built ...
Billionaire and Mt. Lebanon native Mark Cuban didn’t have to think twice Tuesday when asked if he’d support another ...
Accord BioPharma, the U.S. specialty division of Intas Pharmaceuticals, Ltd., focused on the development of oncology and immunology therapies, announced IMULDOSA® (ustekinumab-srlf) is now covered by ...
Prefilled syringes (PFS) preferred on pharmacy benefit; vials preferred on medical benefit RALEIGH, N.C., April 20, 2026 /PRNewswire/ -- Accord BioPharma, the U.S. specialty division of Intas ...
But in ways that are steadily becoming more clear, they are also transforming relationships—adding new uncertainty to what ...
Good morning, and welcome to today's Amneal Pharmaceuticals Investor Call. I will now turn the call over to Amneal's Head of Investor Relations, Tony DiMeo. Good morning, and thank you for joining ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results